Glycoengineering with neuraminic acid analogs to label lipooligosaccharides and detect native sialyltransferase activity in gram-negative bacteria

Erianna I. Alvarado-Melendez, Hanna de Jong, Jet E.M. Hartman, Jun Yang Ong, Marc M.S.M. Wösten*, Tom Wennekes*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Lipooligosaccharides are the most abundant cell surface glycoconjugates on the outer membrane of Gram-negative bacteria. They play important roles in host-microbe interactions. Certain Gram-negative pathogenic bacteria cap their lipooligosaccharides with the sialic acid, N-acetylneuraminic acid (Neu5Ac), to mimic host glycans that among others protects these bacteria from recognition by the hosts immune system. This process of molecular mimicry is not fully understood and remains under investigated. To explore the functional role of sialic acid-capped lipooligosaccharides at the molecular level, it is important to have tools readily available for the detection and manipulation of both Neu5Ac on glycoconjugates and the involved sialyltransferases, preferably in live bacteria. We and others have shown that the native sialyltransferases of some Gram-negative bacteria can incorporate extracellular unnatural sialic acid nucleotides onto their lipooligosaccharides. We here report on the expanded use of native bacterial sialyltransferases to incorporate neuraminic acids analogs with a reporter group into the lipooligosaccharides of a variety of Gram-negative bacteria. We show that this approach offers a quick strategy to screen bacteria for the expression of functional sialyltransferases and the ability to use exogenous CMP-Neu5Ac to decorate their glycoconjugates. For selected bacteria we also show this strategy complements two other glycoengineering techniques, Metabolic Oligosaccharide Engineering and Selective Exo-Enzymatic Labeling, and that together they provide tools to modify, label, detect and visualize sialylation of bacterial lipooligosaccharides.

Original languageEnglish
Number of pages13
JournalGlycobiology
Volume34
Issue number10
DOIs
Publication statusPublished - 30 Aug 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press.

Funding

We thank Prof. dr. Geert-Jan Boons and dr. Gerlof P. Bosman for providing the recombinant sialyltransferases used in the SEEL experiments. Prof. dr. Nina van Sorge and the Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM) for generously providing the N. meningitidis strains L1-L12. Dr. Karin Strijbis and Celia Segui-Perez for providing the Prevotella strains described in this study. Nontypeable H. influenzae R2886 and the siaP mutant were a kind gift from dr. Jeroen Langereis, Radboudumc. Other nontypeable H. influenzae and typeable strains were a kind gift from Clinical Infectiology, Utrecht University. Normal Human Serum (NHS) was a kind gift from prof. dr. Suzan Rooijakkers from UMC Utrecht. Dr. Astrid Heikema from Erasmus MC Rotterdam for providing C. jejuni GB strains and their cstII mutants. Prof. dr. Jos van Putten for the N. gonorrhoeae and N. meningitidis serogroup B, C, W-135 and Y strains. Dr. Maria J. Moure for the Sia-AF488-CMP used in this study.

FundersFunder number
European Union's Horizon 2020 Marie Sklstrok;odowska-Curie Actions for the Innovative Training Network "Sweet Crosstalk"L1-L12
RadboudumcW-135

    Keywords

    • glycoengineering
    • Gram-negative bacteria
    • lipooligosaccharides
    • sialic acid
    • sialyltransferases

    Fingerprint

    Dive into the research topics of 'Glycoengineering with neuraminic acid analogs to label lipooligosaccharides and detect native sialyltransferase activity in gram-negative bacteria'. Together they form a unique fingerprint.

    Cite this